Expertise in
6
conditions

Hans C. Hasselbalch

Roskilde, DK 
Expertise in
6
conditions
Roskilde, DK 

Overview

Hans Hasselbalch practices practicing medicine in Roskilde, Denmark.

Mr. Hasselbalch is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasms (MPN).

He is actively involved in clinical research, co-authoring 229 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Roskilde, 4000, Denmark
Other Locations
Copenhagen, Denmark
Denmark
Herlev, Denmark
Odense, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Myeloproliferative Neoplasms (MPN) and COVID-19
Myeloproliferative Neoplasms (MPN) and COVID-19
Enrollment Status: Completed
Publish Date: September 15, 2025
Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Primary Immune Thrombocytopenia (ITP)
Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Primary Immune Thrombocytopenia (ITP)
Enrollment Status: Withdrawn
Publish Date: September 11, 2019
View 1 Less Clinical Trial

229 Total Publications

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.
Journal: Cancers
Published: July 10, 2026

Frequently Asked Questions about Hans C. Hasselbalch

Is Hans C. Hasselbalch a top-rated expert for Philadelphia-Negative Chronic Myeloid Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Hans C. Hasselbalch is classified as an Elite expert for Philadelphia-Negative Chronic Myeloid Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hans C. Hasselbalch participate in research or clinical trials?

Yes. Hans C. Hasselbalch has published 229 articles and abstracts on conditions like Philadelphia-Negative Chronic Myeloid Leukemia. You can view a list of Hans C. Hasselbalch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hasselbalch's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile